Gossamer Bio (GOSS) Times Interest Earned (2018 - 2026)
Gossamer Bio (GOSS) posted quarterly Times Interest Earned of -$8.71 for Q1 2026, up 35.0% year-over-year from -$6.45 in Q1 2025, and down 13.35% quarter-over-quarter from -$7.69 in Q4 2025.
Gossamer Bio (GOSS) Times Interest Earned (2018 - 2026) Analysis & Trends
Gossamer Bio's Times Interest Earned history runs 9 years deep, the most recent figure standing at -$8.71 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 35.0% year-over-year to -$8.71; the TTM figure through Mar 2026 stood at -$34.72 (down 749.26% YoY), while the FY2025 annual figure was -$0.62, down 138.08% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$8.71, down from -$7.69 in the prior quarter.
- The five-year high for Times Interest Earned was $17.86 in Q2 2024, with the low at -$16.12 in Q3 2022.
- The 5-year median for Times Interest Earned is -$12.41 (2024), against an average of -$9.58.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned surged 232.29% in 2024, then tumbled 132.25% in 2025.
- Gossamer Bio's Times Interest Earned stood at -$9.59 in 2022, then plunged by 57.89% to -$15.14 in 2023, then jumped by 52.26% to -$7.23 in 2024, then declined by 6.39% to -$7.69 in 2025, then fell by 13.35% to -$8.71 in 2026.
- Business Quant data shows GOSS's Times Interest Earned at -$8.71 in Q1 2026, -$7.69 in Q4 2025, and -$0.75 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Gossamer Bio | 49.15 Mn | -7.87 Mn | - | -9.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.46 |
| Mar 31, 2026 | -8.71 |
| Dec 31, 2025 | -7.69 |
| Sep 30, 2025 | -0.75 |
| Jun 30, 2025 | -5.76 |
| Mar 31, 2025 | -13.40 |
| Dec 31, 2024 | -7.23 |
| Sep 30, 2024 | -12.41 |
| Jun 30, 2024 | 17.86 |
| Mar 31, 2024 | -13.41 |
| Dec 31, 2023 | -15.14 |
| Sep 30, 2023 | -12.11 |
| Jun 30, 2023 | -13.50 |
| Mar 31, 2023 | -13.70 |
| Dec 31, 2022 | -9.59 |
| Sep 30, 2022 | -16.12 |
| Jun 30, 2022 | -15.48 |
| Mar 31, 2022 | -15.67 |
| Dec 31, 2021 | -10.46 |
| Sep 30, 2021 | -11.39 |